Mercy Medical Center Highlights GLP-1 Medications for Diabetes Management in Women

Nurse Practitioner Jenepher Piper discusses new treatment options to help older women manage blood sugar levels.

Published on Mar. 9, 2026

Diabetes can be especially debilitating for older women, but Nurse Practitioner Jenepher Piper from Mercy Medical Center in Baltimore, Maryland is highlighting new GLP-1 medication treatments that can help these patients better manage their blood sugar levels.

Why it matters

As the population ages, diabetes has become an increasingly common and serious health issue, especially for older women who face unique challenges in managing the condition. Effective treatments like GLP-1 medications can make a significant difference in improving quality of life and health outcomes for this vulnerable patient group.

The details

GLP-1 medications, or glucagon-like peptide-1 receptor agonists, are a newer class of diabetes drugs that work by stimulating insulin production and reducing glucose levels. Piper explains how these medications can be particularly beneficial for older women with diabetes by helping to control blood sugar, promote weight loss, and reduce the risk of cardiovascular complications.

  • The segment on GLP-1 medications and diabetes management in women aired on March 9, 2026.

The players

Jenepher Piper

A nurse practitioner at Mercy Medical Center in Baltimore, Maryland who specializes in diabetes care.

Mercy Medical Center

A nonprofit hospital system in Baltimore, Maryland that provides a wide range of medical services to the local community.

Got photos? Submit your photos here. ›

What they’re saying

“Diabetes can be particularly debilitating in older women, but there are new treatment options available that can really help manage blood sugar levels.”

— Jenepher Piper, Nurse Practitioner (wbal.com)

The takeaway

By highlighting the benefits of GLP-1 medications for older women with diabetes, Mercy Medical Center is helping to raise awareness of effective treatment options that can improve health outcomes and quality of life for this vulnerable patient population.